Always interesting to see what's addressed and isn't in that article. For me, the most interesting LL comment was this one. She seems to insinuate that anyone could apply for a patent with a small change to the secret sauce but that's just not the answer. So, how does a "tweak" get shareholders to a multi billion dollar market cap before competition swamps them? Or is DCVax the competition to other more established dc therapies??Hmm.
Well, Advent should do well anyway...No, I mean Sawston...No wait, I mean NWBO...No, I mean Advent...No, I'm not sure??
"the patents really are process patents and we could file one that tweaks things a little bit, and that’s essentially that’s what Northwest Bio did. They filed multiple patents just on little tweaks of the cocktails that are used to make the cells."